PUBLISHER: Stratistics Market Research Consulting | PRODUCT CODE: 1402015
PUBLISHER: Stratistics Market Research Consulting | PRODUCT CODE: 1402015
Polymerase Chain Reaction Market Forecasts to 2030 - Global Analysis By Product, Application, End User and By Geography
According to Stratistics MRC, the Global Polymerase Chain Reaction (PCR) Market is accounted for $8.9 billion in 2023 and is expected to reach $19.1 billion by 2030 growing at a CAGR of 11.5% during the forecast period. Polymerase Chain Reaction (PCR) is a molecular method for producing millions of copies of a particular DNA strand through in-vitro amplification. PCR is highly sensitive and can detect minute quantities of DNA. This is particularly advantageous in applications where the target DNA is present in low concentrations, such as in the early stages of certain diseases or when analyzing trace amounts of DNA in forensic samples.
According to Indian Council of Medical Research (ICMR), there will be a 12 percent rise in cancer cases in India by the 2027.
Market Dynamics:
Driver:
Rising demand for genetic testing
The rising demand for genetic testing has been a significant driver in the polymerase chain reaction (PCR) market. Genetic testing involves the analysis of an individual's DNA to identify genetic variations, mutations, and gene expression patterns. PCR plays a crucial role in this process by amplifying specific DNA sequences for further analysis. Additionally, genetic testing has gained popularity among individuals who are curious about their ancestry and want to explore their genetic heritage. Therefore, these advancements have expanded the applications of PCR in genetic testing, contributing to the growth of the PCR market.
Restraint:
High cost
The initial investment in PCR instruments, reagents, and consumables, coupled with the need for skilled personnel, contributes to the overall expense, especially for smaller diagnostic facilities and laboratories. The sophisticated nature of PCR equipment and the continuous requirement for quality control further add to the operational costs. Additionally, the expense of PCR tests may burden patients and healthcare systems, impacting the affordability and equitable distribution of cutting-edge diagnostic services. Therefore, high costs are a significant barrier to market expansion.
Opportunity:
Technological advancements
Real-time PCR allows for the detection and quantification of PCR amplification in real-time, providing immediate results during the amplification process. This real-time monitoring enables faster and more precise analysis, making it valuable in fields such as clinical diagnostics, genetic testing, and research. Furthermore, advancements in PCR instrument technology have resulted in more user-friendly and automated systems. Integrated thermal cyclers with advanced temperature control algorithms and intuitive software interfaces have made PCR more accessible to a broader range of users, including researchers, clinicians, and technicians. These advancements in technology are a significant factor in accelerating market demand.
Threat:
Complexity and technical expertise
A certain level of technical knowledge and training is required for the various steps involved in PCR techniques, which include primer design, reaction condition optimization, and data analysis. PCR protocols require careful design and selection of primers that specifically target the desired DNA regions. Designing primers with appropriate melting temperatures, avoiding secondary structures, and minimizing primer-dimer interactions can be challenging. The complexity and technical expertise required to perform polymerase chain reaction (PCR) act as restraints in the polymerase chain reaction (PCR) market.
COVID-19 Impact
The COVID-19 pandemic significantly impacted the polymerase chain reaction market growth. The growing demand in the clinical diagnostic market segment had a favourable effect on the PCR market. Healthcare professionals advised the population exhibiting COVID-19 symptoms to have a diagnostic test performed, and nearly all of these tests use RT-PCR since viral culture tests have not been recommended by the authorities. Most pharmaceutical and biotechnological companies were focusing on the research and development departments to identify new molecules or leads for the treatment of COVID-19.
The reagents segment is expected to be the largest during the forecast period
The reagents segment is estimated to hold the largest share. PCR reagents encompass a range of chemicals, including DNA polymerases, primers, nucleotides, and buffers, each playing a specific role in the reaction. DNA polymerases, such as Taq polymerase, catalyze the synthesis of complementary DNA strands, while primers provide the starting points for DNA amplification. Nucleotides serve as building blocks for the newly synthesized DNA strands, and buffers maintain the optimal pH conditions for enzymatic activity. The demand for high-quality and reliable reagents is paramount for the accuracy and efficiency of PCR reactions.
The diagnostic center segment is expected to have the highest CAGR during the forecast period
The diagnostic center segment is anticipated to have lucrative growth during the forecast period. PCR technology is extensively utilized in diagnostic centers for the detection of various diseases, including infectious agents, genetic disorders, and cancer. Diagnostic centers leverage PCR's high sensitivity and specificity to identify and quantify specific DNA or RNA sequences, aiding in the early and precise diagnosis of diseases. The versatility of PCR enables diagnostic centers to offer a wide range of tests, contributing to comprehensive patient care.
Region with largest share:
North America commanded the largest market share during the extrapolated period. The high frequency of diseases, the presence of important players in the region, the existence of favourable regulations, and a number of government initiatives pertaining to advancements in healthcare infrastructure all contribute to the growth of the regional market. An additional factor fueling the growth is growing patient awareness of the availability of contemporary products for successful diagnosis.
Region with highest CAGR:
Asia Pacific is expected to witness profitable growth over the projection period, owing to the rising incidence of infectious diseases, the growing recognition of personalized medicine, and the improvements made to the healthcare system. Asian countries are seeing an increase in research endeavours, specifically in the fields of genomics, oncology, and infectious disease investigations. This has led to the widespread use of PCR as a precise and efficient method of amplifying DNA. Moreover, the region's diverse population and genetic variations necessitate robust molecular diagnostics for personalized treatment strategies, further fueling the PCR market.
Key players in the market:
Some of the key players in the Polymerase Chain Reaction (PCR) Market include Danaher Corporation, Fluidigm Corporation, Agilent Technologies, Inc., Stilla Technologies, Abbott, Cytiva, Microsynth AG, Qiagen, JN Medsys, Bio-Rad Laboratories, Inc., Thermo Fisher Scientific, Inc., F. Hoffmann-La Roche Ltd, Siemens, Johnson & Johnson Private Limited and Bruker.
Key Developments:
In August 2022, Abbott and weightwatchers partner to support people living with diabetes in attaining their health goals. Two industry leaders join forces to empower people living with diabetes by providing information and insights to improve weight loss, glucose control and overall health.
In June 2021, Bio-Rad Laboratories, Inc., a global leader of life science research and clinical diagnostic products, announced a partnership with Seegene, Inc., a global leader in multiplex molecular diagnostics, for the clinical development and commercialization of infectious disease molecular diagnostic products.
Products Covered:
- Instruments
- Reagents
- Consumables
- Other Products
Applications Covered:
- Oncology
- Blood Testing
- Pathogen Detection
- Research
- Forensic
- Other Applications
End Users Covered:
- Pharmaceutical
- Hospital
- Clinical Research Organizations
- Diagnostic Center
- Academia
- Laboratories
- Other End Users
Regions Covered:
- North America
- US
- Canada
- Mexico
- Europe
- Germany
- UK
- Italy
- France
- Spain
- Rest of Europe
- Asia Pacific
- Japan
- China
- India
- Australia
- New Zealand
- South Korea
- Rest of Asia Pacific
- South America
- Argentina
- Brazil
- Chile
- Rest of South America
- Middle East & Africa
- Saudi Arabia
- UAE
- Qatar
- South Africa
- Rest of Middle East & Africa
What our report offers:
- Market share assessments for the regional and country-level segments
- Strategic recommendations for the new entrants
- Covers Market data for the years 2021, 2022, 2023, 2026, and 2030
- Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
- Strategic recommendations in key business segments based on the market estimations
- Competitive landscaping mapping the key common trends
- Company profiling with detailed strategies, financials, and recent developments
- Supply chain trends mapping the latest technological advancements
Free Customization Offerings:
All the customers of this report will be entitled to receive one of the following free customization options:
- Company Profiling
- Comprehensive profiling of additional market players (up to 3)
- SWOT Analysis of key players (up to 3)
- Regional Segmentation
- Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
- Competitive Benchmarking
- Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances
Table of Contents
1 Executive Summary
2 Preface
- 2.1 Abstract
- 2.2 Stake Holders
- 2.3 Research Scope
- 2.4 Research Methodology
- 2.4.1 Data Mining
- 2.4.2 Data Analysis
- 2.4.3 Data Validation
- 2.4.4 Research Approach
- 2.5 Research Sources
- 2.5.1 Primary Research Sources
- 2.5.2 Secondary Research Sources
- 2.5.3 Assumptions
3 Market Trend Analysis
- 3.1 Introduction
- 3.2 Drivers
- 3.3 Restraints
- 3.4 Opportunities
- 3.5 Threats
- 3.6 Product Analysis
- 3.7 Application Analysis
- 3.8 End User Analysis
- 3.9 Emerging Markets
- 3.10 Impact of Covid-19
4 Porters Five Force Analysis
- 4.1 Bargaining power of suppliers
- 4.2 Bargaining power of buyers
- 4.3 Threat of substitutes
- 4.4 Threat of new entrants
- 4.5 Competitive rivalry
5 Global Polymerase Chain Reaction (PCR) Market, By Product
- 5.1 Introduction
- 5.2 Instruments
- 5.2.1 Digital PCR Systems
- 5.2.2 Standard PCR Systems
- 5.2.3 Real-Time PCR Systems
- 5.3 Reagents
- 5.4 Consumables
- 5.5 Other Products
6 Global Polymerase Chain Reaction (PCR) Market, By Application
- 6.1 Introduction
- 6.2 Oncology
- 6.3 Blood Testing
- 6.4 Pathogen Detection
- 6.5 Research
- 6.6 Forensic
- 6.7 Other Applications
7 Global Polymerase Chain Reaction (PCR) Market, By End User
- 7.1 Introduction
- 7.2 Pharmaceutical
- 7.3 Hospital
- 7.4 Clinical Research Organizations
- 7.5 Diagnostic Center
- 7.6 Academia
- 7.7 Laboratories
- 7.8 Other End Users
8 Global Polymerase Chain Reaction (PCR) Market, By Geography
- 8.1 Introduction
- 8.2 North America
- 8.2.1 US
- 8.2.2 Canada
- 8.2.3 Mexico
- 8.3 Europe
- 8.3.1 Germany
- 8.3.2 UK
- 8.3.3 Italy
- 8.3.4 France
- 8.3.5 Spain
- 8.3.6 Rest of Europe
- 8.4 Asia Pacific
- 8.4.1 Japan
- 8.4.2 China
- 8.4.3 India
- 8.4.4 Australia
- 8.4.5 New Zealand
- 8.4.6 South Korea
- 8.4.7 Rest of Asia Pacific
- 8.5 South America
- 8.5.1 Argentina
- 8.5.2 Brazil
- 8.5.3 Chile
- 8.5.4 Rest of South America
- 8.6 Middle East & Africa
- 8.6.1 Saudi Arabia
- 8.6.2 UAE
- 8.6.3 Qatar
- 8.6.4 South Africa
- 8.6.5 Rest of Middle East & Africa
9 Key Developments
- 9.1 Agreements, Partnerships, Collaborations and Joint Ventures
- 9.2 Acquisitions & Mergers
- 9.3 New Product Launch
- 9.4 Expansions
- 9.5 Other Key Strategies
10 Company Profiling
- 10.1 Danaher Corporation
- 10.2 Fluidigm Corporation
- 10.3 Agilent Technologies, Inc.
- 10.4 Stilla Technologies
- 10.5 Abbott
- 10.6 Cytiva
- 10.7 Microsynth AG
- 10.8 Qiagen
- 10.9 JN Medsys
- 10.10 Bio-Rad Laboratories, Inc.
- 10.11 Thermo Fisher Scientific, Inc.
- 10.12 F. Hoffmann-La Roche Ltd
- 10.13 Siemens
- 10.14 Johnson & Johnson Private Limited
- 10.15 Bruker
List of Tables
- Table 1 Global Polymerase Chain Reaction (PCR) Market Outlook, By Region (2021-2030) ($MN)
- Table 2 Global Polymerase Chain Reaction (PCR) Market Outlook, By Product (2021-2030) ($MN)
- Table 3 Global Polymerase Chain Reaction (PCR) Market Outlook, By Instruments (2021-2030) ($MN)
- Table 4 Global Polymerase Chain Reaction (PCR) Market Outlook, By Digital PCR Systems (2021-2030) ($MN)
- Table 5 Global Polymerase Chain Reaction (PCR) Market Outlook, By Standard PCR Systems (2021-2030) ($MN)
- Table 6 Global Polymerase Chain Reaction (PCR) Market Outlook, By Real-Time PCR Systems (2021-2030) ($MN)
- Table 7 Global Polymerase Chain Reaction (PCR) Market Outlook, By Reagents (2021-2030) ($MN)
- Table 8 Global Polymerase Chain Reaction (PCR) Market Outlook, By Consumables (2021-2030) ($MN)
- Table 9 Global Polymerase Chain Reaction (PCR) Market Outlook, By Other Products (2021-2030) ($MN)
- Table 10 Global Polymerase Chain Reaction (PCR) Market Outlook, By Application (2021-2030) ($MN)
- Table 11 Global Polymerase Chain Reaction (PCR) Market Outlook, By Oncology (2021-2030) ($MN)
- Table 12 Global Polymerase Chain Reaction (PCR) Market Outlook, By Blood Testing (2021-2030) ($MN)
- Table 13 Global Polymerase Chain Reaction (PCR) Market Outlook, By Pathogen Detection (2021-2030) ($MN)
- Table 14 Global Polymerase Chain Reaction (PCR) Market Outlook, By Research (2021-2030) ($MN)
- Table 15 Global Polymerase Chain Reaction (PCR) Market Outlook, By Forensic (2021-2030) ($MN)
- Table 16 Global Polymerase Chain Reaction (PCR) Market Outlook, By Other Applications (2021-2030) ($MN)
- Table 17 Global Polymerase Chain Reaction (PCR) Market Outlook, By End User (2021-2030) ($MN)
- Table 18 Global Polymerase Chain Reaction (PCR) Market Outlook, By Pharmaceutical (2021-2030) ($MN)
- Table 19 Global Polymerase Chain Reaction (PCR) Market Outlook, By Hospital (2021-2030) ($MN)
- Table 20 Global Polymerase Chain Reaction (PCR) Market Outlook, By Clinical Research Organizations (2021-2030) ($MN)
- Table 21 Global Polymerase Chain Reaction (PCR) Market Outlook, By Diagnostic Center (2021-2030) ($MN)
- Table 22 Global Polymerase Chain Reaction (PCR) Market Outlook, By Academia (2021-2030) ($MN)
- Table 23 Global Polymerase Chain Reaction (PCR) Market Outlook, By Laboratories (2021-2030) ($MN)
- Table 24 Global Polymerase Chain Reaction (PCR) Market Outlook, By Other End Users (2021-2030) ($MN)
- Table 25 North America Polymerase Chain Reaction (PCR) Market Outlook, By Country (2021-2030) ($MN)
- Table 26 North America Polymerase Chain Reaction (PCR) Market Outlook, By Product (2021-2030) ($MN)
- Table 27 North America Polymerase Chain Reaction (PCR) Market Outlook, By Instruments (2021-2030) ($MN)
- Table 28 North America Polymerase Chain Reaction (PCR) Market Outlook, By Digital PCR Systems (2021-2030) ($MN)
- Table 29 North America Polymerase Chain Reaction (PCR) Market Outlook, By Standard PCR Systems (2021-2030) ($MN)
- Table 30 North America Polymerase Chain Reaction (PCR) Market Outlook, By Real-Time PCR Systems (2021-2030) ($MN)
- Table 31 North America Polymerase Chain Reaction (PCR) Market Outlook, By Reagents (2021-2030) ($MN)
- Table 32 North America Polymerase Chain Reaction (PCR) Market Outlook, By Consumables (2021-2030) ($MN)
- Table 33 North America Polymerase Chain Reaction (PCR) Market Outlook, By Other Products (2021-2030) ($MN)
- Table 34 North America Polymerase Chain Reaction (PCR) Market Outlook, By Application (2021-2030) ($MN)
- Table 35 North America Polymerase Chain Reaction (PCR) Market Outlook, By Oncology (2021-2030) ($MN)
- Table 36 North America Polymerase Chain Reaction (PCR) Market Outlook, By Blood Testing (2021-2030) ($MN)
- Table 37 North America Polymerase Chain Reaction (PCR) Market Outlook, By Pathogen Detection (2021-2030) ($MN)
- Table 38 North America Polymerase Chain Reaction (PCR) Market Outlook, By Research (2021-2030) ($MN)
- Table 39 North America Polymerase Chain Reaction (PCR) Market Outlook, By Forensic (2021-2030) ($MN)
- Table 40 North America Polymerase Chain Reaction (PCR) Market Outlook, By Other Applications (2021-2030) ($MN)
- Table 41 North America Polymerase Chain Reaction (PCR) Market Outlook, By End User (2021-2030) ($MN)
- Table 42 North America Polymerase Chain Reaction (PCR) Market Outlook, By Pharmaceutical (2021-2030) ($MN)
- Table 43 North America Polymerase Chain Reaction (PCR) Market Outlook, By Hospital (2021-2030) ($MN)
- Table 44 North America Polymerase Chain Reaction (PCR) Market Outlook, By Clinical Research Organizations (2021-2030) ($MN)
- Table 45 North America Polymerase Chain Reaction (PCR) Market Outlook, By Diagnostic Center (2021-2030) ($MN)
- Table 46 North America Polymerase Chain Reaction (PCR) Market Outlook, By Academia (2021-2030) ($MN)
- Table 47 North America Polymerase Chain Reaction (PCR) Market Outlook, By Laboratories (2021-2030) ($MN)
- Table 48 North America Polymerase Chain Reaction (PCR) Market Outlook, By Other End Users (2021-2030) ($MN)
- Table 49 Europe Polymerase Chain Reaction (PCR) Market Outlook, By Country (2021-2030) ($MN)
- Table 50 Europe Polymerase Chain Reaction (PCR) Market Outlook, By Product (2021-2030) ($MN)
- Table 51 Europe Polymerase Chain Reaction (PCR) Market Outlook, By Instruments (2021-2030) ($MN)
- Table 52 Europe Polymerase Chain Reaction (PCR) Market Outlook, By Digital PCR Systems (2021-2030) ($MN)
- Table 53 Europe Polymerase Chain Reaction (PCR) Market Outlook, By Standard PCR Systems (2021-2030) ($MN)
- Table 54 Europe Polymerase Chain Reaction (PCR) Market Outlook, By Real-Time PCR Systems (2021-2030) ($MN)
- Table 55 Europe Polymerase Chain Reaction (PCR) Market Outlook, By Reagents (2021-2030) ($MN)
- Table 56 Europe Polymerase Chain Reaction (PCR) Market Outlook, By Consumables (2021-2030) ($MN)
- Table 57 Europe Polymerase Chain Reaction (PCR) Market Outlook, By Other Products (2021-2030) ($MN)
- Table 58 Europe Polymerase Chain Reaction (PCR) Market Outlook, By Application (2021-2030) ($MN)
- Table 59 Europe Polymerase Chain Reaction (PCR) Market Outlook, By Oncology (2021-2030) ($MN)
- Table 60 Europe Polymerase Chain Reaction (PCR) Market Outlook, By Blood Testing (2021-2030) ($MN)
- Table 61 Europe Polymerase Chain Reaction (PCR) Market Outlook, By Pathogen Detection (2021-2030) ($MN)
- Table 62 Europe Polymerase Chain Reaction (PCR) Market Outlook, By Research (2021-2030) ($MN)
- Table 63 Europe Polymerase Chain Reaction (PCR) Market Outlook, By Forensic (2021-2030) ($MN)
- Table 64 Europe Polymerase Chain Reaction (PCR) Market Outlook, By Other Applications (2021-2030) ($MN)
- Table 65 Europe Polymerase Chain Reaction (PCR) Market Outlook, By End User (2021-2030) ($MN)
- Table 66 Europe Polymerase Chain Reaction (PCR) Market Outlook, By Pharmaceutical (2021-2030) ($MN)
- Table 67 Europe Polymerase Chain Reaction (PCR) Market Outlook, By Hospital (2021-2030) ($MN)
- Table 68 Europe Polymerase Chain Reaction (PCR) Market Outlook, By Clinical Research Organizations (2021-2030) ($MN)
- Table 69 Europe Polymerase Chain Reaction (PCR) Market Outlook, By Diagnostic Center (2021-2030) ($MN)
- Table 70 Europe Polymerase Chain Reaction (PCR) Market Outlook, By Academia (2021-2030) ($MN)
- Table 71 Europe Polymerase Chain Reaction (PCR) Market Outlook, By Laboratories (2021-2030) ($MN)
- Table 72 Europe Polymerase Chain Reaction (PCR) Market Outlook, By Other End Users (2021-2030) ($MN)
- Table 73 Asia Pacific Polymerase Chain Reaction (PCR) Market Outlook, By Country (2021-2030) ($MN)
- Table 74 Asia Pacific Polymerase Chain Reaction (PCR) Market Outlook, By Product (2021-2030) ($MN)
- Table 75 Asia Pacific Polymerase Chain Reaction (PCR) Market Outlook, By Instruments (2021-2030) ($MN)
- Table 76 Asia Pacific Polymerase Chain Reaction (PCR) Market Outlook, By Digital PCR Systems (2021-2030) ($MN)
- Table 77 Asia Pacific Polymerase Chain Reaction (PCR) Market Outlook, By Standard PCR Systems (2021-2030) ($MN)
- Table 78 Asia Pacific Polymerase Chain Reaction (PCR) Market Outlook, By Real-Time PCR Systems (2021-2030) ($MN)
- Table 79 Asia Pacific Polymerase Chain Reaction (PCR) Market Outlook, By Reagents (2021-2030) ($MN)
- Table 80 Asia Pacific Polymerase Chain Reaction (PCR) Market Outlook, By Consumables (2021-2030) ($MN)
- Table 81 Asia Pacific Polymerase Chain Reaction (PCR) Market Outlook, By Other Products (2021-2030) ($MN)
- Table 82 Asia Pacific Polymerase Chain Reaction (PCR) Market Outlook, By Application (2021-2030) ($MN)
- Table 83 Asia Pacific Polymerase Chain Reaction (PCR) Market Outlook, By Oncology (2021-2030) ($MN)
- Table 84 Asia Pacific Polymerase Chain Reaction (PCR) Market Outlook, By Blood Testing (2021-2030) ($MN)
- Table 85 Asia Pacific Polymerase Chain Reaction (PCR) Market Outlook, By Pathogen Detection (2021-2030) ($MN)
- Table 86 Asia Pacific Polymerase Chain Reaction (PCR) Market Outlook, By Research (2021-2030) ($MN)
- Table 87 Asia Pacific Polymerase Chain Reaction (PCR) Market Outlook, By Forensic (2021-2030) ($MN)
- Table 88 Asia Pacific Polymerase Chain Reaction (PCR) Market Outlook, By Other Applications (2021-2030) ($MN)
- Table 89 Asia Pacific Polymerase Chain Reaction (PCR) Market Outlook, By End User (2021-2030) ($MN)
- Table 90 Asia Pacific Polymerase Chain Reaction (PCR) Market Outlook, By Pharmaceutical (2021-2030) ($MN)
- Table 91 Asia Pacific Polymerase Chain Reaction (PCR) Market Outlook, By Hospital (2021-2030) ($MN)
- Table 92 Asia Pacific Polymerase Chain Reaction (PCR) Market Outlook, By Clinical Research Organizations (2021-2030) ($MN)
- Table 93 Asia Pacific Polymerase Chain Reaction (PCR) Market Outlook, By Diagnostic Center (2021-2030) ($MN)
- Table 94 Asia Pacific Polymerase Chain Reaction (PCR) Market Outlook, By Academia (2021-2030) ($MN)
- Table 95 Asia Pacific Polymerase Chain Reaction (PCR) Market Outlook, By Laboratories (2021-2030) ($MN)
- Table 96 Asia Pacific Polymerase Chain Reaction (PCR) Market Outlook, By Other End Users (2021-2030) ($MN)
- Table 97 South America Polymerase Chain Reaction (PCR) Market Outlook, By Country (2021-2030) ($MN)
- Table 98 South America Polymerase Chain Reaction (PCR) Market Outlook, By Product (2021-2030) ($MN)
- Table 99 South America Polymerase Chain Reaction (PCR) Market Outlook, By Instruments (2021-2030) ($MN)
- Table 100 South America Polymerase Chain Reaction (PCR) Market Outlook, By Digital PCR Systems (2021-2030) ($MN)
- Table 101 South America Polymerase Chain Reaction (PCR) Market Outlook, By Standard PCR Systems (2021-2030) ($MN)
- Table 102 South America Polymerase Chain Reaction (PCR) Market Outlook, By Real-Time PCR Systems (2021-2030) ($MN)
- Table 103 South America Polymerase Chain Reaction (PCR) Market Outlook, By Reagents (2021-2030) ($MN)
- Table 104 South America Polymerase Chain Reaction (PCR) Market Outlook, By Consumables (2021-2030) ($MN)
- Table 105 South America Polymerase Chain Reaction (PCR) Market Outlook, By Other Products (2021-2030) ($MN)
- Table 106 South America Polymerase Chain Reaction (PCR) Market Outlook, By Application (2021-2030) ($MN)
- Table 107 South America Polymerase Chain Reaction (PCR) Market Outlook, By Oncology (2021-2030) ($MN)
- Table 108 South America Polymerase Chain Reaction (PCR) Market Outlook, By Blood Testing (2021-2030) ($MN)
- Table 109 South America Polymerase Chain Reaction (PCR) Market Outlook, By Pathogen Detection (2021-2030) ($MN)
- Table 110 South America Polymerase Chain Reaction (PCR) Market Outlook, By Research (2021-2030) ($MN)
- Table 111 South America Polymerase Chain Reaction (PCR) Market Outlook, By Forensic (2021-2030) ($MN)
- Table 112 South America Polymerase Chain Reaction (PCR) Market Outlook, By Other Applications (2021-2030) ($MN)
- Table 113 South America Polymerase Chain Reaction (PCR) Market Outlook, By End User (2021-2030) ($MN)
- Table 114 South America Polymerase Chain Reaction (PCR) Market Outlook, By Pharmaceutical (2021-2030) ($MN)
- Table 115 South America Polymerase Chain Reaction (PCR) Market Outlook, By Hospital (2021-2030) ($MN)
- Table 116 South America Polymerase Chain Reaction (PCR) Market Outlook, By Clinical Research Organizations (2021-2030) ($MN)
- Table 117 South America Polymerase Chain Reaction (PCR) Market Outlook, By Diagnostic Center (2021-2030) ($MN)
- Table 118 South America Polymerase Chain Reaction (PCR) Market Outlook, By Academia (2021-2030) ($MN)
- Table 119 South America Polymerase Chain Reaction (PCR) Market Outlook, By Laboratories (2021-2030) ($MN)
- Table 120 South America Polymerase Chain Reaction (PCR) Market Outlook, By Other End Users (2021-2030) ($MN)
- Table 121 Middle East & Africa Polymerase Chain Reaction (PCR) Market Outlook, By Country (2021-2030) ($MN)
- Table 122 Middle East & Africa Polymerase Chain Reaction (PCR) Market Outlook, By Product (2021-2030) ($MN)
- Table 123 Middle East & Africa Polymerase Chain Reaction (PCR) Market Outlook, By Instruments (2021-2030) ($MN)
- Table 124 Middle East & Africa Polymerase Chain Reaction (PCR) Market Outlook, By Digital PCR Systems (2021-2030) ($MN)
- Table 125 Middle East & Africa Polymerase Chain Reaction (PCR) Market Outlook, By Standard PCR Systems (2021-2030) ($MN)
- Table 126 Middle East & Africa Polymerase Chain Reaction (PCR) Market Outlook, By Real-Time PCR Systems (2021-2030) ($MN)
- Table 127 Middle East & Africa Polymerase Chain Reaction (PCR) Market Outlook, By Reagents (2021-2030) ($MN)
- Table 128 Middle East & Africa Polymerase Chain Reaction (PCR) Market Outlook, By Consumables (2021-2030) ($MN)
- Table 129 Middle East & Africa Polymerase Chain Reaction (PCR) Market Outlook, By Other Products (2021-2030) ($MN)
- Table 130 Middle East & Africa Polymerase Chain Reaction (PCR) Market Outlook, By Application (2021-2030) ($MN)
- Table 131 Middle East & Africa Polymerase Chain Reaction (PCR) Market Outlook, By Oncology (2021-2030) ($MN)
- Table 132 Middle East & Africa Polymerase Chain Reaction (PCR) Market Outlook, By Blood Testing (2021-2030) ($MN)
- Table 133 Middle East & Africa Polymerase Chain Reaction (PCR) Market Outlook, By Pathogen Detection (2021-2030) ($MN)
- Table 134 Middle East & Africa Polymerase Chain Reaction (PCR) Market Outlook, By Research (2021-2030) ($MN)
- Table 135 Middle East & Africa Polymerase Chain Reaction (PCR) Market Outlook, By Forensic (2021-2030) ($MN)
- Table 136 Middle East & Africa Polymerase Chain Reaction (PCR) Market Outlook, By Other Applications (2021-2030) ($MN)
- Table 137 Middle East & Africa Polymerase Chain Reaction (PCR) Market Outlook, By End User (2021-2030) ($MN)
- Table 138 Middle East & Africa Polymerase Chain Reaction (PCR) Market Outlook, By Pharmaceutical (2021-2030) ($MN)
- Table 139 Middle East & Africa Polymerase Chain Reaction (PCR) Market Outlook, By Hospital (2021-2030) ($MN)
- Table 140 Middle East & Africa Polymerase Chain Reaction (PCR) Market Outlook, By Clinical Research Organizations (2021-2030) ($MN)
- Table 141 Middle East & Africa Polymerase Chain Reaction (PCR) Market Outlook, By Diagnostic Center (2021-2030) ($MN)
- Table 142 Middle East & Africa Polymerase Chain Reaction (PCR) Market Outlook, By Academia (2021-2030) ($MN)
- Table 143 Middle East & Africa Polymerase Chain Reaction (PCR) Market Outlook, By Laboratories (2021-2030) ($MN)
- Table 144 Middle East & Africa Polymerase Chain Reaction (PCR) Market Outlook, By Other End Users (2021-2030) ($MN)
